Ride the Tiger with CD Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ride the Tiger with CD

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocket Red who wrote (161625)	5/29/2009 11:38:06 PM
From: Cheeky Kid	Read Replies (1) of 313137

PharmaGap's PHG-alpha-1 arrives at NCI 2009-05-07 08:45 ET - News Release Shares issued 45,402,332 GAP Close 2009-05-06 C$ 0.19 Mr. Robert McInnis reports PHARMAGAP PROVIDES GUIDANCE ON TIMING OF TESTING AT NATIONAL CANCER INSTITUTE The National Cancer Institute (NCI) has confirmed receipt of PharmaGap Inc.'s drug product PhG-alpha-1 at its drug depository in Rockville, Md., in advance of testing in the NCI's tumour cell panel consisting of 60 human cancer cell lines. The NCI has advised the company that the results of the initial single dose test could normally be expected in a minimum of six to 10 weeks. ------------------------------ Thats minimum wait, whats the average wait?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next